Key result
Cardiomyocyte Trbp deletion accelerates heart failure and fibrosis via Tgfβ2-driven fibroblast activation.
Why the study?
Trbp is an RNA-binding protein essential during heart development, but its role in the adult heart and cardiac remodeling remained unknown.
Does cardiomyocyte-specific deletion of Trbp accelerate cardiac fibrosis and heart failure via the TGF-beta signaling pathway in preclinical rodent models of pressure overload?
Does cardiomyocyte-specific deletion of Trbp accelerate cardiac fibrosis and heart failure via the TGF-beta signaling pathway in preclinical rodent models of pressure overload?
Trbp inhibits maladaptive cardiac fibrosis during pressure overload by repressing Tgfb2 expression in cardiomyocytes, preventing paracrine TGF-beta-mediated activation of cardiac fibroblasts.
Answers are grounded in this paper and cite their sources.
Cardiomyocyte Trbp loss accelerates post-TAC fibrosis and HF in mice; hypothesis-generating for TGF-β crosstalk, should not yet change practice.
Cardiac remodeling in response to disease or tissue damage severely impairs heart function. Therefore, the description of the molecular mechanisms responsible is essential for the development of effective therapies. Trbp (Tarbp2) is a multifunctional RNA-binding protein that is essential during heart development, but its role in the adult heart and cardiac remodeling remains unknown. We generated inducible conditional knockout mice to delete Trbp from cardiomyocytes in young adults (Trbp-cKOs). While Trbp-cKO mice did not display a detectable phenotype, under stress conditions induced by transverse aortic constriction pressure overload, they rapidly developed severe heart failure; this was associated with maladaptive cardiac remodeling and increased interstitial fibrosis. RNA-sequencing revealed the induction of a fibrotic gene expression network and the TGF-β signaling pathway in Trbp-cKO hearts. In cultured neonatal rat ventricle cardiomyocytes (NRCMs), inhibition of Trbp resulted in an induction of the expression of both Tgfβ2 and Ltbp2; in contrast, Trbp overexpression repressed Tgfβ2 expression. Knockdown of Trbp in NRCMs that were co-cultured with neonatal rat cardiac fibroblasts (NRCFs) resulted in an increase in fibrotic gene expression. However, knockdown of Trbp in NRCMs combined with knockdown of Tgfβ2 in NRCFs using the same co-culture system failed to induce the same change in fibrotic gene expression. These data provide evidence for a critical role for Trbp in regulating cardiac fibrosis during cardiac remodeling mediated by cross-talk between cardiomyocytes and fibroblasts. The link to TGF-β signaling also highlights its importance and reveals a novel approach to intervention by targeting of Trbp.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied Pressure overload-induced cardiac remodeling and cardiac fibrosis. Cardiomyocyte-specific Trbp deletion (induced by tamoxifen 30 mg/kg IP daily for 5 days) combined with transverse aortic constriction (TAC) surgery; in vitro siRNA knockdown or adenoviral overexpression of Trbp vs. Corn oil vehicle-injected control mice and sham-operated mice; negative control siRNA or GFP adenovirus in vitro was evaluated on Ventricular function (LVEF, LVFS, LV mass), interstitial cardiac fibrosis (% myocardial area), and fibrotic/TGF-beta pathway gene expression (Tgfβ2, Ltbp2, Col1a1, Col3a1, Postn) (p=<0.05). Cardiomyocyte-specific Trbp deletion accelerated heart failure and interstitial fibrosis after pressure overload in mice by upregulating Tgfβ2 and Ltbp2 to activate fibroblast cross-talk.
Synapse has enriched 10 related papers. Consider them for comparative context: